252 related articles for article (PubMed ID: 24629239)
1. Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer.
Romain B; Hachet-Haas M; Rohr S; Brigand C; Galzi JL; Gaub MP; Pencreach E; Guenot D
Mol Cancer; 2014 Mar; 13():58. PubMed ID: 24629239
[TBL] [Abstract][Full Text] [Related]
2. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs.
Liu H; Xue W; Ge G; Luo X; Li Y; Xiang H; Ding X; Tian P; Tian X
Biochem Biophys Res Commun; 2010 Oct; 401(4):509-15. PubMed ID: 20869949
[TBL] [Abstract][Full Text] [Related]
3. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration.
Chen D; Xia Y; Zuo K; Wang Y; Zhang S; Kuang D; Duan Y; Zhao X; Wang G
Sci Rep; 2015 Nov; 5():16813. PubMed ID: 26578388
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in human osteosarcoma.
Guo M; Cai C; Zhao G; Qiu X; Zhao H; Ma Q; Tian L; Li X; Hu Y; Liao B; Ma B; Fan Q
PLoS One; 2014; 9(3):e90518. PubMed ID: 24618817
[TBL] [Abstract][Full Text] [Related]
8. CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1α.
Esencay M; Sarfraz Y; Zagzag D
BMC Cancer; 2013 Jul; 13():347. PubMed ID: 23865743
[TBL] [Abstract][Full Text] [Related]
9. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
11. The potential role of stromal cell-derived factor-1α/CXCR4/CXCR7 axis in adipose-derived mesenchymal stem cells.
Ji F; Wang Y; Yuan J; Wu Q; Wang J; Liu D
J Cell Physiol; 2020 Apr; 235(4):3548-3557. PubMed ID: 31566725
[TBL] [Abstract][Full Text] [Related]
12. Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas.
Tarnowski M; Grymula K; Reca R; Jankowski K; Maksym R; Tarnowska J; Przybylski G; Barr FG; Kucia M; Ratajczak MZ
Mol Cancer Res; 2010 Jan; 8(1):1-14. PubMed ID: 20068066
[TBL] [Abstract][Full Text] [Related]
13. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
[TBL] [Abstract][Full Text] [Related]
14. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4.
Arora S; Bhardwaj A; Singh S; Srivastava SK; McClellan S; Nirodi CS; Piazza GA; Grizzle WE; Owen LB; Singh AP
J Biol Chem; 2013 Jul; 288(29):21197-21207. PubMed ID: 23740244
[TBL] [Abstract][Full Text] [Related]
15. CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.
Kumar R; Tripathi V; Ahmad M; Nath N; Mir RA; Chauhan SS; Luthra K
Cell Immunol; 2012; 272(2):230-41. PubMed ID: 22070874
[TBL] [Abstract][Full Text] [Related]
16. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
[TBL] [Abstract][Full Text] [Related]
17. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.
Oh YS; Kim HY; Song IC; Yun HJ; Jo DY; Kim S; Lee HJ
Oncol Rep; 2012 Dec; 28(6):2239-46. PubMed ID: 23023480
[TBL] [Abstract][Full Text] [Related]
19. CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells.
Tarnowski M; Liu R; Wysoczynski M; Ratajczak J; Kucia M; Ratajczak MZ
Eur J Haematol; 2010 Dec; 85(6):472-83. PubMed ID: 20887389
[TBL] [Abstract][Full Text] [Related]
20. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
